These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14563003)

  • 1. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates.
    Ding M; Day JS; Burr DB; Mashiba T; Hirano T; Weinans H; Sumner DR; Hvid I
    Calcif Tissue Int; 2003 Jun; 72(6):737-44. PubMed ID: 14563003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone.
    Hu JH; Ding M; Søballe K; Bechtold JE; Danielsen CC; Day JS; Hvid I
    Bone; 2002 Nov; 31(5):591-7. PubMed ID: 12477573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
    Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
    J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.
    Allen MR; Burr DB
    Osteoporos Int; 2008 Jan; 19(1):95-9. PubMed ID: 17710353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography.
    Borah B; Dufresne TE; Chmielewski PA; Gross GJ; Prenger MC; Phipps RJ
    J Bone Miner Res; 2002 Jul; 17(7):1139-47. PubMed ID: 12096826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.
    Tang SY; Allen MR; Phipps R; Burr DB; Vashishth D
    Osteoporos Int; 2009 Jun; 20(6):887-94. PubMed ID: 18850239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent- and Tissue-Level Yield Behaviors of L4 Vertebral Trabecular Bone and Their Associations with Microarchitectures.
    Gong H; Wang L; Fan Y; Zhang M; Qin L
    Ann Biomed Eng; 2016 Apr; 44(4):1204-23. PubMed ID: 26104807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone.
    Wang X; Allen MR; Burr DB; Lavernia EJ; Jeremić B; Fyhrie DP
    Bone; 2008 Oct; 43(4):775-80. PubMed ID: 18599390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
    Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
    Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related variations in the microstructure of human tibial cancellous bone.
    Ding M; Odgaard A; Linde F; Hvid I
    J Orthop Res; 2002 May; 20(3):615-21. PubMed ID: 12038639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of periarticular cancellous morphology and mechanical stiffness in post-traumatic experimental osteoarthritis by antiresorptive therapy.
    MacNeil JA; Doschak MR; Zernicke RF; Boyd SK
    Clin Biomech (Bristol, Avon); 2008 Mar; 23(3):365-71. PubMed ID: 18078697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate treatment changes regional distribution of trabecular microstructure in human lumbar vertebrae.
    Vom Scheidt A; Hemmatian H; Püschel K; Krause M; Amling M; Busse B
    Bone; 2019 Oct; 127():482-487. PubMed ID: 31280018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse.
    Yang Li C; Majeska RJ; Laudier DM; Mann R; Schaffler MB
    Bone; 2005 Sep; 37(3):287-95. PubMed ID: 16006205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.
    Mashiba T; Hirano T; Turner CH; Forwood MR; Johnston CC; Burr DB
    J Bone Miner Res; 2000 Apr; 15(4):613-20. PubMed ID: 10780852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.
    Mashiba T; Hui S; Turner CH; Mori S; Johnston CC; Burr DB
    Calcif Tissue Int; 2005 Sep; 77(3):180-5. PubMed ID: 16265598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and material mechanical properties of human vertebral cancellous bone.
    Nicholson PH; Cheng XG; Lowet G; Boonen S; Davie MW; Dequeker J; Van der Perre G
    Med Eng Phys; 1997 Dec; 19(8):729-37. PubMed ID: 9450257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site.
    Boyce RW; Paddock CL; Gleason JR; Sletsema WK; Eriksen EF
    J Bone Miner Res; 1995 Feb; 10(2):211-21. PubMed ID: 7754801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.
    Callaci JJ; Juknelis D; Patwardhan A; Sartori M; Frost N; Wezeman FH
    Alcohol Clin Exp Res; 2004 Jan; 28(1):182-91. PubMed ID: 14745317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.